XRP2 fundamentals
An in-depth look to SILENCE THERAPEUTICS PLC operating, investing, and financing activities
XRP2 free cash flow for Q3 24 is -21.97 M EUR. For 2023, XRP2 free cash flow was -43.29 M EUR and operating cash flow was -43.24 M EUR.
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM